C93.90
Monocytic leukemia, unspecified, not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Monocytic leukemia, unspecified with failed remission
- Monocytic leukemia, unspecified NOS
Medical Intelligence & Overview
Monocytic leukemia is a type of blood cancer that affects monocytes, a kind of white blood cell involved in immune defense. When this condition is diagnosed but the specific subtype isn't identified, or if the disease has not responded to treatment, it is classified under the ICD-10 code C93.90. This form of leukemia is characterized by an abnormal growth of monocytes and can influence various parts of the body, including the bone marrow and bloodstream. Understanding this condition can help patients grasp the nature of their diagnosis and the importance of ongoing medical care.
Causes & Symptoms
Clinical Causes: Genetic mutations in blood-forming cells Exposure to radiation or certain chemicals Previous chemotherapy or radiation treatments Inherited genetic predispositions Environmental factors that damage bone marrow
Key Symptoms: Persistent tiredness or fatigue Unexplained fever or chills Frequent or severe infections Easy bruising or bleeding Swelling or pain in the bones or joints Unintentional weight loss Night sweats Paleness or anemia symptoms Enlarged lymph nodes or spleen
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of blood tests, bone marrow biopsies, and imaging studies. Blood tests may reveal abnormal levels of white blood cells, anemia, or other irregularities. A Bone marrow biopsy helps confirm the presence of monocytic leukemia and determines the extent of blood cell involvement. Additional tests, such as cytogenetic analysis, can identify specific genetic abnormalities. The diagnosis of 'unspecified' or 'not having achieved remission' indicates that a definitive subtype classification was not made or that previous treatment efforts have not been successful, respectively.
Treatment Protocols: Managing monocytic leukemia often requires a combination of treatments, which may include chemotherapy to destroy cancerous cells, targeted therapy aimed at specific genetic mutations, and supportive care to address symptoms and prevent complications. For patients not achieving remission, treatment adjustments or alternative therapies might be necessary. In some cases, stem cell transplants could be considered. Throughout treatment, regular monitoring is crucial to assess response and adapt the therapy plan accordingly. Clinical trials may also be an option for some patients seeking new treatment avenues.
Clinical Advice & FAQs
Billing Guidance
Is C93.90 a billable ICD-10 code?
Yes, C93.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C93.90?
Clinical documentation must specify the nature of Monocytic leukemia, unspecified, not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference